Division of Pediatric Gastroenterology, University of Iowa, Iowa City, Iowa, USA.
Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
JPEN J Parenter Enteral Nutr. 2018 May;42(4):690-701. doi: 10.1177/0148607117722753. Epub 2017 Dec 19.
Intestinal failure is a chronic condition related to loss of bowel length and/or function, resulting in dependence on central venous catheters for fluids and nutrition. Catheter use can be associated with significant complications, including catheter-related bloodstream infections (CRBSIs), which can lead to loss of vascular access, advancing intestinal failure associated-liver disease and death. Our objective was to evaluate the effectiveness and safety of ethanol locks as compared with standard heparin locks in pediatric intestinal failure.
Databases, including MEDLINE and EMBASE, were searched until March 2017. Titles and abstracts were reviewed independently and relevant articles reassessed by full-text review. The main outcome was the rate of CRBSIs, while secondary outcomes were catheter replacement and repair.
Nine observational studies were included. The mean difference in rate of CRBSIs was 6.27 per 1000 catheter days (95% CI, 4.89-7.66) favoring ethanol locks, with a 63% overall reduction in infection rate. The mean difference in catheter replacement rate (per 1000 catheter days) was 4.56 (95% Cl, 2.68-6.43) favoring ethanol locks. The overall effect on catheter repair rate (per 1000 catheter days) was -1.67 (95% CI, -2.30 to -1.05), indicating lower repair rate with heparin locks.
Sufficient evidence was noted showing that ethanol locks reduced CRBSIs and catheter replacements. Our findings raise questions about the effect of the ethanol lock on catheter integrity based on the noted increase in repair rate. This requires further prospective evaluation and may support selective application of ethanol locks to patients with documented CRBSIs.
肠衰竭是一种与肠长度和/或功能丧失相关的慢性疾病,导致需要依赖中心静脉导管来提供液体和营养。导管的使用可能会导致严重的并发症,包括导管相关血流感染(CRBSI),这可能导致血管通路丧失、进展性肠衰竭相关肝病和死亡。我们的目的是评估乙醇锁与标准肝素锁在儿科肠衰竭中的有效性和安全性。
检索了包括 MEDLINE 和 EMBASE 在内的数据库,截至 2017 年 3 月。独立审查标题和摘要,并通过全文审查重新评估相关文章。主要结果是 CRBSI 的发生率,次要结果是导管更换和修复。
纳入了 9 项观察性研究。乙醇锁组的 CRBSI 发生率的平均差异为每 1000 个导管日 6.27 例(95%CI,4.89-7.66),感染率总体降低了 63%。导管更换率的平均差异(每 1000 个导管日)为 4.56(95%Cl,2.68-6.43),有利于乙醇锁。导管修复率的总体效果(每 1000 个导管日)为-1.67(95%CI,-2.30 至-1.05),表明肝素锁的修复率较低。
有足够的证据表明,乙醇锁可降低 CRBSI 和导管更换率。我们的发现提出了一个问题,即乙醇锁对导管完整性的影响,基于修复率的增加。这需要进一步的前瞻性评估,并可能支持根据已记录的 CRBSI 选择性应用乙醇锁。